CN103284961B - Preparing method of cobamamide freeze-drying formulation for injection - Google Patents

Preparing method of cobamamide freeze-drying formulation for injection Download PDF

Info

Publication number
CN103284961B
CN103284961B CN201310245278.0A CN201310245278A CN103284961B CN 103284961 B CN103284961 B CN 103284961B CN 201310245278 A CN201310245278 A CN 201310245278A CN 103284961 B CN103284961 B CN 103284961B
Authority
CN
China
Prior art keywords
injection
cobamamide
amount
water
add
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310245278.0A
Other languages
Chinese (zh)
Other versions
CN103284961A (en
Inventor
门毅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Kang Yi Pharmaceutical Co., Ltd.
Original Assignee
门毅
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 门毅 filed Critical 门毅
Priority to CN201310245278.0A priority Critical patent/CN103284961B/en
Publication of CN103284961A publication Critical patent/CN103284961A/en
Application granted granted Critical
Publication of CN103284961B publication Critical patent/CN103284961B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a cobamamide freeze-drying formulation for injection and a preparing method thereof. According to a specific amount, the amount ratio of adenosylcobalamin, mannitol and water for injection is 0.52 g: 25 g: 500 ml. The preparing method comprises: operating in a dark environment, weighing mannitol according to a prescribed amount, adding the water for injection in an amount of about 90%, then stirring to achieve complete dissolution, adding cobamamide, and stirring to achieve complete dissolution; adding the water for injection to the full amount, stirring evenly, adding activated carbon in a preparation amount of 0.02% (W/V), and fully stirring; performing coarsely filtered decarburization of the obtained solution, then performing refined filtration with a 0.22 [mu]m microporous filtering membrane, determining the content, and calculating a package amount; sub-packaging; and performing freeze drying to obtain the final product. The method is simple in operation, has no need of any additional stabilizers and inert gas for protection, and has high product stability.

Description

A kind of preparation method of cobamamide lyophilized preparation for injection
technical field:
The present invention relates to the preparation method of pharmaceutical preparation, specifically a kind of cobamamide lyophilized preparation for injection with and preparation method thereof.
background technology:
Cobamamide, claims again Cobamamide, and chemistry 5,6-dimethylbenzimidazole base-5-deoxyadenosine base cobalt amine by name, is one of active coenzyme form of vitamin B12.The cobamamide initial stage is mainly used in treating pernicious anemia, also share with folic acid, is used for the treatment of anemia that various megaloblastic anemias, antifolic cause etc., and it is also for nervous system disease.Its range of application is constantly expanded in recent ten years, now is also usually used in treating the diseases such as radiculitis, polyneuritis, peripheral neuritis, ophthalmoplegia.Its application in fields such as hepatopathy, cancer, chronic atrophic gastritis, reproductive system diseases has also had new progress.Cobamamide dosage form comprises cobamamide tablet and injection cobamamide lyophilized injectable powder.Due to cobamamide crude drug poor chemical stability, especially to photaesthesia, thereby, in the time of preparation injection cobamamide lyophilized injectable powder, conventionally to add the agent of the plurality of stable such as antibacterial, chelating agent, and prepare in lucifuge environment at present.But because operator can not carry out work under the environment of complete lucifuge, and the bad control of lucifuge condition, so sometimes also need to pass into inert gas shielding and add stabilizing agent.Even if but in the situation that adding stabilizing agent, the stability of product is still not ideal enough.Moreover stabilizing agent can be brought potential hazard to health.Therefore, clinical needing badly obtains one and prepares simply, containing stabilizing agent, and the more stable cobamamide lyophilized injectable powder of product quality.
summary of the invention:
Object of the present invention is exactly that a kind of new method of preparing cobamamide lyophilized preparation for injection will be provided, to for the clinical one that provides is containing stabilizing agent, and the more stable cobamamide lyophilized injectable powder of product quality.Applicant of the present invention gropes by a large amount of reagent screening and great many of experiments, has finally determined proportioning and the preparation method of the cobamamide lyophilized formulations with optimum stability.
The object of the present invention is achieved like this:
The preparation method of cobamamide lyophilized preparation for injection provided by the present invention, comprises the following steps:
1, drug component
Cobamamide, mannitol, water for injection, its amount ratio is: 0.52g:25g:500ml.By every batch of 1000 calculating, its consumption part is such as following table:
prescription composition
Specification 0.5mg 1.0mg 1.5mg
Cobamamide * 0.52g 1.04g 1.56g
Mannitol 25g 50g 75g
Water for injection 500ml 1000ml 1500ml
Subpackage volume 0.5ml 1.0ml 1.5ml
*: cobamamide consumption is the theoretical value of calculating by dry product, at middle conversion moisture and the content of needing that feeds intake.
2, solution preparation
Under lucifuge environment, operate, take mannitol by recipe quantity, add the water for injection of recipe quantity approximately 90%, stirring makes entirely molten, adds cobamamide, and stirring makes entirely molten; Add to the full amount of water for injection, stir, add the active carbon of amount of preparation 0.2 ‰ (W/V), fully stir.Solution, after the de-charcoal of coarse filtration, then is used 0.22um microporous filter membrane fine straining; Regulate pH value 5.5-7.0.
3, assay, pH value, visible foreign matters, calculating loading amount
4, aseptic filtration, fill
Filter and draw aseptic filtration liquid with 0.22um, after the diverter that filtrate enters filling machine through pipeline, to fill syringe needle, get medicinal liquid 20 times.By aseptic filtration liquid debugging loading amount;
Carry out subpackage according to assay value, every content of dispersion is respectively: 0.5mg; 1.0mg; 1.5mg(theoretical volume should be respectively 0.5ml, 1.0ml, 1.5ml) embedding is to the brown cillin bottle of 2ml.
5, lyophilization
(1) pre-freeze: open cryodesiccation chamber's refrigeration machine, put into sample, sample temperature is down to-40 DEG C of left and right, maintain 5 hours;
(2) sublimation drying: open vacuum pump, sublimation drying;
A. the first stage: it is 5 DEG C/h that flaggy heating rate is set, is warming up to-20 DEG C, maintains this temperature to solid ice and completely rises and eliminate;
B. second stage: it is 5 DEG C/h that flaggy heating rate is set, and sample temperature is risen to 25 DEG C, maintains 25 DEG C and reaches requirement to sample moisture, checks drying baker vacuum, to without obviously becoming.
6, in case, compress plug, put into pure air and make to reach normal pressure, take out product
The chemical stabilizer such as bacteriostatic agent, chelating agent, opacifier not in the inventive method, but by ratio and the rational technology controlling and process of best cobamamide and mannitol and water, the adjuvant amount that this product is used is less, and less on the impact of principal agent is that stability is better; Preparation is simultaneously simple, does not need to pass into inert gas shielding in whole process.The main component of lyophilizing liquid is that mannitol is easy to lyophilizing, when lyophilization, adopt the method for gradient sublimation drying, guarantee can distil and unlikelyly make too fast distillation and make proppant distortion, can be good at controlling the moisture in final products, has therefore further improved again the stability of product.
detailed description of the invention:
The first step: solution preparation
Take mannitol 50g by recipe quantity, add the water for injection of the about 900ml of recipe quantity, stirring makes entirely molten, adds cobamamide 1.02g, and stirring makes entirely molten; Inject water to 1000ml, stir, add the active carbon of amount of preparation 0.2 ‰ (W/V), fully stir.Solution, after the de-charcoal of coarse filtration, then is used 0.22um microporous filter membrane fine straining, regulates pH value 5.5-7.0.
Second step: assay, pH value, visible foreign matters, calculating loading amount
Lucifuge operation.Get cobamamide reference substance 25mg, accurately weighed, put in 100ml measuring bottle, be dissolved in water and be diluted to scale, precision measures 2ml, puts in 10ml measuring bottle, is diluted with water to scale, shakes up, in contrast product solution; Get 10 of this product, be dissolved in water and move in 250ml measuring bottle, water gradation washing container, washing liquid is incorporated in measuring bottle, and is diluted to scale, shakes up, as need testing solution.Get respectively the each 10 μ l of reference substance solution and need testing solution, injection liquid chromatography, records chromatogram, by external standard method with calculated by peak area content.
The 3rd step: aseptic filtration, fill
Filter and draw aseptic filtration liquid with 0.22um, after the diverter that filtrate enters filling machine through pipeline, to fill syringe needle, get medicinal liquid 20 times.By aseptic filtration liquid debugging loading amount;
Carry out subpackage according to assay value, every content of dispersion is respectively: 0.5mg; 1.0mg; 1.5mg(theoretical volume should be respectively 0.5ml, 1.0ml, 1.5ml) embedding is to the brown cillin bottle of 2ml.
The 4th step: lyophilization
(1) pre-freeze: open cryodesiccation chamber's refrigeration machine, put into sample, sample temperature is down to-40 DEG C of left and right, maintain 5 hours;
(2) sublimation drying: open vacuum pump, sublimation drying;
A. the first stage: it is 5 DEG C/h that flaggy heating rate is set, is warming up to-20 DEG C, maintains this temperature to solid ice and completely rises and eliminate;
B. second stage: it is 5 DEG C/h that flaggy heating rate is set, and sample temperature is risen to 25 DEG C, maintains 25 DEG C and reaches requirement to sample moisture, checks drying baker vacuum, to without significant change.
The 5th step: compress plug in case, put into pure air and make to reach normal pressure, take out product.
The 6th step: entirely examine by standard.
The 7th step: after qualified, label, mounted box, vanning, warehouse-in.
Finally it should be noted that, above embodiment is only unrestricted in order to technical scheme of the present invention to be described, although the present invention is had been described in detail with reference to preferred embodiment, those of ordinary skill in the art is to be understood that, can modify or be equal to replacement technical scheme of the present invention, and not departing from the spirit and scope of technical solution of the present invention, it all should be encompassed in the middle of claim scope of the present invention.

Claims (2)

1. a cobamamide lyophilized preparation for injection, is characterized in that: cobamamide, mannitol, water for injection, and its amount ratio is: 0.52g:25g:500ml; And adopt with the following method and prepare:
(1) solution preparation;
Under lucifuge environment, operate, take mannitol by recipe quantity, add the water for injection of recipe quantity approximately 90%, stirring makes entirely molten, adds cobamamide, and stirring makes entirely molten; Add to the full amount of water for injection, stir, add the active carbon of amount of preparation 0.2 ‰ (W/V), fully stir, solution, after the de-charcoal of coarse filtration, then is used 0.22um microporous filter membrane fine straining; Regulate pH value 5.5-7.0;
(2) assay, pH value, visible foreign matters, calculating loading amount;
(3) aseptic filtration, fill;
Filter and draw aseptic filtration liquid with 0.22um, after the diverter that filtrate enters filling machine through pipeline, to fill syringe needle, get medicinal liquid 20 times, by aseptic filtration liquid debugging loading amount;
Carry out subpackage according to assay value, every content of dispersion is respectively: 0.5mg; 1.0mg; 1.5mg, embedding is to the brown cillin bottle of 2ml;
(4) lyophilization;
1. pre-freeze: open cryodesiccation chamber's refrigeration machine, put into sample, sample temperature is down to-40 DEG C of left and right, maintain 5 hours;
2. sublimation drying: open vacuum pump, sublimation drying;
A. the first stage: it is 5 DEG C/h that flaggy heating rate is set, is warming up to-20 DEG C, maintains this temperature to solid ice and completely rises and eliminate;
B. second stage: it is 5 DEG C/h that flaggy heating rate is set, and sample temperature is risen to 25 DEG C, maintains 25 DEG C and reaches requirement to sample moisture, checks drying baker vacuum, to without significant change;
(5) in case, compress plug, put into pure air and make to reach normal pressure, take out product.
2. prepare a method for cobamamide lyophilized preparation for injection, its feature is as follows:
(1) drug component: cobamamide, mannitol, water for injection, its amount ratio is: 0.52g:25g:500ml;
(2) solution preparation;
Under lucifuge environment, operate, take mannitol by recipe quantity, add the water for injection of recipe quantity approximately 90%, stirring makes entirely molten, adds cobamamide, and stirring makes entirely molten; Add to the full amount of water for injection, stir, add the active carbon of amount of preparation 0.2 ‰ (W/V), fully stir, solution, after the de-charcoal of coarse filtration, then is used 0.22um microporous filter membrane fine straining; Regulate pH value 5.5-7.0;
(3) assay, pH value, visible foreign matters, calculating loading amount;
(4) aseptic filtration, fill;
Filter and draw aseptic filtration liquid with 0.22um, after the diverter that filtrate enters filling machine through pipeline, to fill syringe needle, get medicinal liquid 20 times, by aseptic filtration liquid debugging loading amount;
Carry out subpackage according to assay value, every content of dispersion is respectively: 0.5mg; 1.0mg; 1.5mg, embedding is to the brown cillin bottle of 2ml;
(5) lyophilization;
1. pre-freeze: open cryodesiccation chamber's refrigeration machine, put into sample, sample temperature is down to-40 DEG C of left and right, maintain 5 hours;
2. sublimation drying: open vacuum pump, sublimation drying;
A. the first stage: it is 5 DEG C/h that flaggy heating rate is set, is warming up to-20 DEG C, maintains this temperature to solid ice and completely rises and eliminate;
B. second stage: it is 5 DEG C/h that flaggy heating rate is set, and sample temperature is risen to 25 DEG C, maintains 25 DEG C and reaches requirement to sample moisture, checks drying baker vacuum, to without significant change;
(6) in case, compress plug, put into pure air and make to reach normal pressure, take out product.
CN201310245278.0A 2013-06-20 2013-06-20 Preparing method of cobamamide freeze-drying formulation for injection Active CN103284961B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310245278.0A CN103284961B (en) 2013-06-20 2013-06-20 Preparing method of cobamamide freeze-drying formulation for injection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310245278.0A CN103284961B (en) 2013-06-20 2013-06-20 Preparing method of cobamamide freeze-drying formulation for injection

Publications (2)

Publication Number Publication Date
CN103284961A CN103284961A (en) 2013-09-11
CN103284961B true CN103284961B (en) 2014-06-18

Family

ID=49086859

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310245278.0A Active CN103284961B (en) 2013-06-20 2013-06-20 Preparing method of cobamamide freeze-drying formulation for injection

Country Status (1)

Country Link
CN (1) CN103284961B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105267161B (en) * 2015-11-24 2019-05-14 河北智同生物制药股份有限公司 A kind of cobamamide lyophilized preparation for injection composition and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101785780A (en) * 2010-04-07 2010-07-28 海南资福医药有限公司 Preparation of cyanocobalamine and adenosine composition and preparation method thereof
CN102379851A (en) * 2010-09-03 2012-03-21 华北制药股份有限公司 Preparation method of cobamamide lyophilized preparation for injection

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101785780A (en) * 2010-04-07 2010-07-28 海南资福医药有限公司 Preparation of cyanocobalamine and adenosine composition and preparation method thereof
CN102379851A (en) * 2010-09-03 2012-03-21 华北制药股份有限公司 Preparation method of cobamamide lyophilized preparation for injection

Also Published As

Publication number Publication date
CN103284961A (en) 2013-09-11

Similar Documents

Publication Publication Date Title
CN101411710A (en) Pemetrexed disodium freeze-dried injection and preparation method thereof
CN102133199A (en) Doxofylline lyophilized preparation for injection and preparation method thereof
CN108992400B (en) Pharmaceutical composition containing irinotecan hydrochloride and preparation method thereof
CN104414983B (en) A kind of injection fosaprepitant dimeglumine sterile lyophilized powder and its preparation process
CN102038651B (en) Ropivacaine mesylate freeze-dried powder injection
CN101874770A (en) Clindamycin phosphate injection and preparation method thereof
CN103284961B (en) Preparing method of cobamamide freeze-drying formulation for injection
CN102657622A (en) Preparation process of freeze-dry powder injection containing esomeprazole sodium
CN102973524A (en) Esomeprazole sodium lyophilized powder injection and preparation method thereof
CN103463614B (en) A kind of Argatroban injection and preparation method thereof
CN102784382A (en) Argatroban drug composition and preparation method and application of argatroban drug composition
CN105079015B (en) Troxerutin freeze-dried powder injection and preparation method thereof
CN101940557B (en) Method for preparing fat-soluble vitamin freeze-dried powder injection
CN100571685C (en) The preparation technology of a kind of ropivacaine and officinal salt lyophilized injectable powder thereof
CN103040855A (en) Pharmaceutical composition of fludarabine phosphate and preparation method thereof
CN104606209A (en) Compound vitamin medicine composition for injection and preparation method of compound vitamin medicine composition
CN104606220A (en) Multivitamin composition and preparation method thereof
CN102824345A (en) Irinotecan hydrochloride composition and preparation method thereof
CN102743342A (en) Sodium fusidate lyophilized composition for injection
CN103520122B (en) Preparation method for Bumetanide freeze-dried powder preparation for injection
CN105147724B (en) A kind of Mannitol sodium chloride injection and preparation method thereof
CN105726495B (en) A kind of short-acting benzodiazepine salt pharmaceutical composition of injection and preparation method thereof
CN103040758B (en) A kind of pharmaceutical composition containing cefathiamidine compound and preparation method thereof
CN103054816A (en) Aprotinin freeze-dried powder and preparation method thereof
CN102813631A (en) Method for preparing phentolamine mesilate freeze-drying powder injection

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20170704

Address after: 100160 Beijing Fengtai District City Jincheng Tianlun building 4, unit 7, room 902

Patentee after: Sun Wei

Address before: 100021 Beijing city Chaoyang District Jinsong three District No. 302 Huateng building room 906

Patentee before: Men Yi

TR01 Transfer of patent right

Effective date of registration: 20180608

Address after: 102212 east side cottage of Beijing Changping District City Xing Shou Town Xing Shou Garden Technology Development Center

Patentee after: Beijing Kang Yi Pharmaceutical Co., Ltd.

Address before: 100160 room 902, unit 7, building 4, Tianlun Jincheng, Fengtai District, Beijing.

Patentee before: Sun Wei

TR01 Transfer of patent right